-
公开(公告)号:US12295362B2
公开(公告)日:2025-05-13
申请号:US17592105
申请日:2022-02-03
Applicant: Allogene Therapeutics, Inc.
Inventor: Muneeswara Babu Medi , Zhuojin Xu , Jung S. Lee , Yajin Ni , Mark W. Leonard
IPC: A01N1/125 , A61K40/11 , A61K40/31 , A61K40/42 , C12N5/0783
Abstract: Provided herein are formulations and drug product processes that can improve cell viability and minimize waste of the manufactured formulated cells for a drug product.